Vector Science and Therapeutics Corp. (PAIN.V) announced a 12‑month investor relations agreement with RedChip Companies, Inc., effective August 24, 2026. Under the terms, Vector will pay RedChip $8,500 per month in advance for services that include outreach to investment advisors, analysts, portfolio managers and media contacts. RedChip will also help the company develop investor materials such as presentations and website disclosures to support planned institutional and analyst engagement.
The contract is for a one‑year period and may be extended or modified if both parties agree in writing. Additionally, Vector has granted RedChip options to purchase up to 150,000 common shares at C$1.80 per share. These options, which expire on August 24, 2029, will vest quarterly throughout the duration of the investor relations agreement.
All arrangements are subject to approval by the TSX Venture Exchange. RedChip, a U.S.‑based investor relations firm, operates independently and is not affiliated with Vector. Neither RedChip nor its principals currently hold any common shares in the company.
The agreement is designed to bolster Vector’s investor outreach as the company advances its portfolio of novel biomechanical devices and localized drug‑delivery platforms. PAIN.V’s stock has ranged from $0.35 to $2.65 over the past year; it is currently trading at $1.80, reflecting a 5.76 % decline.
